Speaker Profile
Ph.D., CEO, Vector Bioscience Cambrid
Biography
David is a Professor of Molecular Engineering at the University of Cambridge, and a leader revolutionizing cancer treatment with innovative drug delivery systems. David leverages over 15 years of research experience to spearhead advancements in precision medicine. His pioneering work with metal-organic frameworks (MOFs) has led to groundbreaking developments in targeted and controlled release of any modalities, significantly improving existing technologies such as LNPs and ADCs. David has been leading Vector's technology, achieving exceptional drug delivery efficiency and stability, showcasing potential in treating hard-to-treat cancers.
Talk
Revolutionizing Cancer Treatment with Advanced Drug Delivery Systems
Vector Bioscience Cambridge leverages advanced porous nanoshuttles to transform cancer therapy. Our platform offers targeted, controlled drug release of multiple modalities, including functional payloads and RNA, enhancing bioavailability in tumor tissues while minimizing side effects. Discover how our versatile delivery system optimizes therapeutic efficacy, paving the way for groundbreaking advancements in hard-to-treat cancers and beyond.
Emerging Therapeutics Showcase:
Vector Bioscience Cambrid
Vector is pioneering the use of advanced porous nanoshuttles to revolutionize cancer treatment, enabling precision medicine with targeted and controlled drug delivery. Our versatile platform significantly enhances therapeutic efficacy while minimizing side effects, addressing critical challenges in treating hard-to-reach and metastatic cancers.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2024 Emerging Therapeutics Showcase will provide a 15-minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
